David Zaccardelli, President and CEO at Verona Pharma plc (VRNA), sold 180,720 shares at $8.98 ($1.6M) on 2025-04-29, disclosed to the SEC on 2025-05-01.
Scheduled sale ($1.6M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.98 | 90,360 | $811K | 50.0% |
| 2 | $8.98 | 90,360 | $811K | 50.0% |
| Total | $8.98 avg | 180,720 | $1.6M | 100% |
| Filing → |
| VRNA | SELL | 2025-05-29 | $7.1M | — | Filing → |
| VRNA | SELL | 2025-05-05 | $7.0M | — | Filing → |
| VRNA | SELL | 2024-12-06 | $7.6M | — | Filing → |